Skip to main content
SpringerLink
Log in

Controversies in the Management of Solid Tumor Bone Metastases

  • Chapter
  • First Online:
Controversies in Radiation Oncology

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 648 Accesses

Abstract

Bone metastases from solid tumor origin are challenging to manage and require a coordinated multi-specialist effort. Skeletal related events result in a significant societal burden and the predominant goal of the orthopedic oncologist is palliation of pain and preservation of function. Given the wide range of clinical scenarios that may be encountered, controversies exist both within and among specialties. This chapter reviews the current landscape in the management of bone metastases with a focus on commonly encountered sub-sites including long bones, spine, and periacetabular metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Balain BA, Jaiswal A, Trivedi JM, Eisenstein SM, Kuiper JH, Jaffray DC (2013) The Oswestry Risk Index: an aid in the treatment of metastatic disease of the spine. Bone Joint J 95-B(2):210–216

    Article  CAS  PubMed  Google Scholar 

  • Barzilai O, Amato MK, McLaughlin L, Reiner AS, Ogilvie SQ, Lis E, Yamada Y, Bilsky MH, Laufer I (2018) Hybrid surgery-radiosurgery therapy for metastatic epidural spinal cord compression: a prospective evaluation using patient-reported outcomes. Neurooncol Pract 5(2):104–113

    PubMed  Google Scholar 

  • Barzilai O, Versteeg AL, Sahgal A, Rhines LD, Bilsky MH, Sciubba DM et al (2019) Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study. Cancer 125(5):770–778

    Article  PubMed  Google Scholar 

  • Berenson J, Pflugmacher R, Jarzem P, Zonder J, Schechtman K, Tillman JB, Bastian L, Ashraf T, Vrionis F, Cancer Patient Fracture Evaluation (CAFE) Investigators (2011) Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol 12(3):225–235

    Article  PubMed  Google Scholar 

  • Bilsky MH, Laufer I, Burch S (2005) Shifting paradigms in the treatment of metastatic spine disease. Spine 34(22):S101–S107

    Google Scholar 

  • Breast Cancer NCCN Evidence Blocks (2018) NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Version 3.2018 – Nov. 13, 2018

    Google Scholar 

  • Capanna R, Campanacci DA (2001) The treatment of metastases in the appendicular skeleton. J Bone Joint Surg (Br) 83(4):471–481

    Article  CAS  Google Scholar 

  • Cassidy JT, Baker JF, Lenehan B (2018) The role of prognostic scoring systems in assessing surgical candidacy for patients with vertebral metastasis: a narrative review. Global Spine J 8(6):638–651

    Article  PubMed  PubMed Central  Google Scholar 

  • Cheon PM, Wong E, Thavarajah N, Dennis K, Lutz S et al (2015) A definition of “uncomplicated bone metastases” based on previous bone metastases radiation trials comparing single-fractions and multi-fraction radiation therapy. J Bone Oncol 4(1):13–17

    Article  PubMed  PubMed Central  Google Scholar 

  • Choosing Wisely, American Society for Radiation Oncology (ASTRO) (2015). http://www.choosingwisely.org/wp-content/uploads/2015/02/ASTRO-Choosing-Wisely-List.pdf

  • Choudhury KB, Mallik C, Sharma S, Choudhury DB, Maiti S et al (2011) A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis. Indian J Palliat Care 17(3):210–218

    Article  PubMed  PubMed Central  Google Scholar 

  • Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S (2012) Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol 24:112–124

    Article  CAS  Google Scholar 

  • Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS et al (2014) Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 15(2):164–171

    Article  PubMed  Google Scholar 

  • Enneking W, Dunham W, Gebhardt M, Malawar M, Pritchard D (1990) A system for the classification of skeletal resections. Chir Organi Mov 75(1):217–240

    CAS  PubMed  Google Scholar 

  • Lutz ST, Lo SSM, Chang EL, Galanopoulos N, et al. Expert Panel on Radiation Oncology-Bone Metastases (2012) ACR appropriateness criteria® non-spine bone metastases. J Palliat Med 15(5)

    Google Scholar 

  • Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH et al (2010) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine 35(22):E1221–E1229

    Article  PubMed  Google Scholar 

  • Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R, Goessl C (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377(9768):813–822

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH et al (2011) Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 29(22):3072–3077

    Article  PubMed  Google Scholar 

  • Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 32(2):193–199

    Article  PubMed  Google Scholar 

  • Gravalos C, Rodriguez C, Sabino A, Segui MA, Virizuela JA, Carmona A, Cassinello J, Isla D, Jara C, Martin M (2016) SEOM clinical guideline for bone metastases from solid tumours. Clin Transl Oncol 18(12):1243–1253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hansen-Algenstaedt N, Kwan MK, Algenstaedt P, Chiu CK, Viezens L, Chan TS, Lee CK, Wellbrock J, Chan CYW, Schaefer C (2017a) Comparison between minimally invasive surgery and conventional open surgery for patients with spinal metastasis: a prospective propensity score-matched study. Spine 42(10):789–797

    Article  PubMed  Google Scholar 

  • Hansen-Algenstaedt N, Kwan MK, Algenstaedt P, Chiu CK, Viezens L et al (2017b) Comparison between minimally invasive surgery and conventional open surgery for patients with spinal metastasis: a prospective propensity score-matched study. Spine 42(10):789–797

    Article  PubMed  Google Scholar 

  • Harel R, Angelov L (2010) Spine metastases: current treatments and future directions. Eur J Cancer 46(15):2696–2707

    Article  PubMed  Google Scholar 

  • Harrington KD (1981) The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 63(4):653–664

    Article  CAS  PubMed  Google Scholar 

  • Henry D, Vadhan-Raj S, Hirsh V, von Moos R, Hungria V, Costa L, Woll PJ, Scagliotti G, Smith G, Feng A, Jun S, Dansey R, Yeh H (2014) Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Support Care Cancer 22(3):679–687

    Article  PubMed  Google Scholar 

  • Hernandez RK, Adhia A, Wade SW, O’Connor E, Arellano J, Francis K, Alvrtsyan H, Million RP, Liede A (2015) Prevalence of bone metastases and bone-targeting agent using solid tumor patients in the United States. Clin Epidemiol 7:335–345

    PubMed  PubMed Central  Google Scholar 

  • Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer 18:44

    Article  PubMed  PubMed Central  Google Scholar 

  • Himelstein AL, Qin R, Novotny PJ, Seisler DK, Khatcheressian JL, Roberts JD et al (2015) CALGB 70604 (Alliance): a randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer. J Clin Oncol 33(suppl):abstr 9501

    Article  Google Scholar 

  • Hortobayi GN, Lipton A, Chew HC, Gradishar WJ, Sauter N, Mohanlal R et al (2014) Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer: results of the OPTIMIZE-2 trial. J Clin Oncol 32:5s

    Google Scholar 

  • Hoskin P, Sundar S, Reczko K, Forsyth S, Mithal N et al (2015) A multicenter randomized trial of ibandronate compared with single-dose radiotherapy for localized metastatic bone pain in prostate cancer. J Natl Cancer Inst 107(10)

    Google Scholar 

  • Hospital Outpatient Quality Reporting Program (2016) Fact Sheet for OP-33: External Beam Radiotherapy for Bone Metastases. https://www.qualityreportingcenter.com/wp-content/uploads/2016/03/HOQR-OP-33-Fact-Sheet.508.pdf

  • Ji T, Guo W, Yang R-L, Tang S, Sun X (2011) Clinical outcome and quality of life after surgery for peri-acetabular metastases. J Bone Joint Surg (Br) 93-B:1104–1110

    Article  Google Scholar 

  • Johnson S (2018) What percentage of bones in the body comprise the axial skeleton? Sciencing, https://sciencing.com/what-percentage-of-bones-in-the-body-comprise-the-axial-skeleton-12761249.html. Accessed 16 Nov 2018

  • Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, Watanabe T, Goessl C, Ohashi Y, Takashima S (2005) Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol 23(15):3314–3321

    Article  CAS  PubMed  Google Scholar 

  • Konski A (2004) Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys 60(5):1373–1378

    Article  PubMed  Google Scholar 

  • Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, Rehak P, Windhager R (2008) Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 17(11):1488–1495

    Article  PubMed  PubMed Central  Google Scholar 

  • Lovelock DM, Zhang Z, Jackson A, Keam J, Bekelman J et al (2010) Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases. Int J Radiat Oncol Biol Phys 77(4):1282–1287

    Article  PubMed  PubMed Central  Google Scholar 

  • Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, Wong R, Hahn C (2017) Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 7:4–12

    Article  PubMed  Google Scholar 

  • Marco RAW (2018) Metastatic spine disease: a guide to diagnosis and management. Springer, Berlin

    Book  Google Scholar 

  • Mirels H (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 249:256–264

    Google Scholar 

  • Muller DA, Capanna R (2015) The surgical treatment of pelvic bone metastases. Adv Orthop 2015:525363

    Article  PubMed  PubMed Central  Google Scholar 

  • Patchell RA, Tibbs PA, Regine WF, Payne R et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648

    Article  PubMed  Google Scholar 

  • Rades D, Rudat V, Veninga T, Stalpers LJ, Basic H et al (2008a) A score predicting post treatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 72(3):905–908

    Article  PubMed  Google Scholar 

  • Rades D, Dunst J, Schild SE (2008b) The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer 112(1):157–161

    Article  PubMed  Google Scholar 

  • Rades D, Douglas S, Huttenlocher S, Rudat V, Veninga T et al (2011) Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 79(5):1503–1506

    Article  PubMed  Google Scholar 

  • Roos DE (2000) Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol 56:315–322

    Article  CAS  PubMed  Google Scholar 

  • Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, De Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman J (2004) Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer 100(12):2613–2621

    Article  CAS  PubMed  Google Scholar 

  • Rutter CE, Yu JB, Wilson LD, Park HS (2015) Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States. Int J Radiat Oncol Biol Phys 91(3):548–555

    Article  PubMed  Google Scholar 

  • Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M, Zoledronic Acid Prostate Cancer Study Group (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96(11):879–882

    Article  CAS  PubMed  Google Scholar 

  • Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, García-Sáenz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I (2012a) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7(12):1823–1829

    Article  CAS  PubMed  Google Scholar 

  • Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ et al (2012b) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7(12):1823–1829

    Article  CAS  PubMed  Google Scholar 

  • Steenland E, Leer J, van Houwelingen H, Post WJ, van den Hout WB et al (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101–109

    Article  CAS  PubMed  Google Scholar 

  • Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28(35):5132–5139

    Article  CAS  PubMed  Google Scholar 

  • Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30(19):2186–2191

    Article  PubMed  Google Scholar 

  • Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine 26(3):298–306

    Article  CAS  PubMed  Google Scholar 

  • Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RES (1995) Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys 31(1):43–49

    Article  CAS  PubMed  Google Scholar 

  • Wilkinson AN, Viola R, Brundage MD (2008) Managing skeletal related events resulting from bone metastases. BMJ 337:A2041

    Article  PubMed  Google Scholar 

  • Wood TJ, Racano A, Yeung H, Farrokhyar F, Ghert M, Deheshi BM (2014) Surgical management of bone metastases: quality of evidence and systematic review. Ann Surg Oncol 21(13):4081–4089

    Article  PubMed  Google Scholar 

  • Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490

    Article  PubMed  Google Scholar 

  • Yamada Y, Cox B, Zelefsky MJ et al (2011) An analysis of prognostic factors for local control of malignant spine tumors treated with spine radiosurgery. Int J Radiat Oncol Biol Phys 81:S132–S133

    Article  Google Scholar 

  • Yamada K, Yoshimura M, Kaise H, Ogata A, Ueda N et al (2012) Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases. Exp Ther Med 3(2):226–230

    Article  CAS  PubMed  Google Scholar 

  • Zuckerman SL, Laufer I, Sahgal A, Yamada YJ, Schmidt MH et al (2016) When less is more: the indications for MIS techniques and separation surgery in metastatic spine disease. Spine 41(20):S246–S253

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA

    Andrew M. Farach, E. Brian Butler & Bin S. Teh

Authors
  1. Andrew M. Farach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Brian Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin S. Teh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew M. Farach .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA, USA

    Simon S. Lo

  2. Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA

    Bin S. Teh

  3. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

    Guo-Liang Jiang

  4. Department of Radiation Oncology, University of Washington, Seattle, WA, USA

    Nina A. Mayr

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Farach, A.M., Butler, E.B., Teh, B.S. (2019). Controversies in the Management of Solid Tumor Bone Metastases. In: Lo, S., Teh, B., Jiang, GL., Mayr, N. (eds) Controversies in Radiation Oncology. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2019_217

Download citation

  • DOI: https://doi.org/10.1007/174_2019_217

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51194-8

  • Online ISBN: 978-3-319-51196-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation